Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/James Rose
BARC
James Rose
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-11.6%
Average Return
0 of 2 calls profitable · -19.9% vs benchmark
📈 Across the calls we could measure, roughly 0% of James Rose's ratings turned a profit when each position was held for 1 year — averaging -11.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

40 Buy 2 Hold 1 Sell
James's Stock Coverage 19 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
GB:DPLM
Diploma
Jun 08, 2026 BUY Strong Buy
-23.9% avg upside
8 analysts
$8300.00
15.22% Upside
·
GB:ZIG
ZIGUP plc
May 22, 2026 BUY Strong Buy
+2509.8% avg upside
3 analysts
$500.00
6.80% Upside
·
GB:RS1
RS Group PLC
May 21, 2026 BUY Strong Buy
+22.9% avg upside
10 analysts
$800.00
28.88% Upside
·
GB:EXPN
Experian
May 21, 2026 BUY Buy
+280.1% avg upside
19 analysts
$4500.00
77.08% Upside
·
GB:RTO
Rentokil Initial
Apr 14, 2026 BUY Strong Buy
+23.2% avg upside
19 analysts
$630.00
46.81% Upside
·
GB:BNZL
Bunzl plc
Mar 19, 2026 HOLD Hold
+6.9% avg upside
16 analysts
$2250.00
9.10% Downside
·
GB:CPI
Capita plc
Mar 11, 2026 BUY Strong Buy
+2356.5% avg upside
5 analysts
$600.00
87.89% Upside
·
NL:RAND
Randstad Holding NV
Mar 11, 2026 SELL Hold
+41.9% avg upside
14 analysts
$42.00
55.56% Upside
·
FR:ERF
Eurofins Scientific
Jul 16, 2025 HOLD Hold
+22.0% avg upside
16 analysts
$54.00
13.67% Downside
·
GB:SRP
Serco Group plc
Jul 07, 2025 BUY Buy
+0.7% avg upside
8 analysts
$260.00
9.57% Upside
·
GB:ITRK
Intertek
Nov 27, 2024 SELL Hold
+797.2% avg upside
23 analysts
$4750.00
18.20% Downside
·
CH:SGSN
SGS SA
Nov 21, 2024 SELL Buy
+1111.7% avg upside
25 analysts
$91.00
0.17% Upside
·
FR:BVI
Bureau Veritas
Oct 24, 2024 BUY Buy
+12.2% avg upside
24 analysts
$33.00
26.89% Upside
·
GB:DCC
DCC plc
Dec 16, 2022 SELL Strong Buy
+1.6% avg upside
10 analysts
$4100.00
33.88% Downside
·
BZLFY
Bunzl
Dec 16, 2022 SELL Sell
+73.8% avg upside
4 analysts
$36.92
123.57% Upside
-15.8%
GB:PAGE
PageGroup
Oct 19, 2022 HOLD Hold
+136.6% avg upside
8 analysts
$600.00
439.60% Upside
·
GB:HAS
Hays plc
Jul 18, 2022 BUY Buy
+9248.1% avg upside
11 analysts
$190.00
478.85% Upside
·
FERG
Ferguson PLC
Mar 16, 2022 BUY Strong Buy
+1.9% avg upside
28 analysts
$174.54
26.68% Downside
-7.3%
GB:TPK
Travis Perkins
Jan 24, 2022 HOLD Buy
+80.2% avg upside
8 analysts
$1545.00
185.34% Upside
·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
James Rose — Frequently Asked Questions
How accurate are James Rose's stock ratings?
Based on the calls 13Foresight could measure, about 0% of James's ratings were profitable over a one-year hold, with an average return of -11.6% per rating, or -19.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is James ranked on 13Foresight?
James Rose is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does James cover?
James most recently has ratings on GB:DPLM, GB:ZIG, GB:RS1, GB:EXPN, GB:RTO, GB:BNZL, GB:CPI, NL:RAND, FR:ERF, GB:SRP, GB:ITRK, CH:SGSN and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.